Journal
Journal of Clinical and Translational Science
Publication Date
2-6-2026
Volume
10
Issue
1
First Page
e43
Document Type
Open Access Publication
DOI
10.1017/cts.2026.10699
Rights and Permissions
Hively A, La Manna A, Clark E, Luke D, de Silva A, Agarwal M, Huffman MD, Salam A, Agarwal A, Tetteh EK. Leveraging the Translational Science Benefits Model to plan and measure early impact in the heart failure polypill implementation trial in Sri Lanka. J Clin Transl Sci. 2026 Feb 6;10(1):e43. doi: 10.1017/cts.2026.10699 This is an Open Access article, distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. © The Author(s), 2026. Published by Cambridge University Press on behalf of Association for Clinical and Translational Science
Recommended Citation
Hively, Adam; La Manna, Anna; Clark, Ella; Luke, Douglas; de Silva, Asita; Agarwal, Mansi; Huffman, Mark D; Salam, Abdul; Agarwal, Anubha; and Tetteh, Emmanuel K, "Leveraging the Translational Science Benefits Model to plan and measure early impact in the heart failure polypill implementation trial in Sri Lanka." Journal of Clinical and Translational Science. 10, 1. e43 (2026).
https://digitalcommons.wustl.edu/oa_4/7225
Department
ICTS (Institute of Clinical and Translational Sciences)
